August 26, 2015
Corium Announces Issuance of U.S. Patent for MicroCor® Transdermal System for a Broad Range of Therapeutics and Vaccines
“Drug-in-Tip” Patent Provides Coverage of Dissolving Microstructure Arrays as an Alternative to Injections…
August 25, 2015
Corium Initiates Phase 1 Clinical Trial of CorplexTM Donepezil Transdermal System for the Treatment of Alzheimer’s Disease
MENLO PARK, Calif. , Aug. 25, 2015 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced the commencement of dosing in a Phase 1…
August 5, 2015
Corium Prices Follow-On Offering of Common Stock
MENLO PARK, Calif. , Aug. 5, 2015 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced the pricing of its underwritten public…
August 3, 2015
Corium Announces Proposed Public Offering of Common Stock
MENLO PARK, Calif. , Aug. 3, 2015 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced today that it has commenced an underwritten public…